Executives On The Move: New CEO Appointed At La Jolla Pharmaceutical, COO Named At Mesoblast
Executive Summary
Also, NeuBase Therapeutics has secured a new chief operating officer and Amgen has named a new vice president-finance/chief accounting officer.